EP

Eversept Partners Portfolio holdings

AUM $1.78B
1-Year Est. Return 97.69%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+97.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$605M
AUM Growth
+$226M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
81
New
Increased
Reduced
Closed

Top Buys

1 +$40.8M
2 +$26.2M
3 +$20M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$18.2M
5
AZN icon
AstraZeneca
AZN
+$10.8M

Top Sells

1 +$29.3M
2 +$27.8M
3 +$20.4M
4
APLS icon
Apellis Pharmaceuticals
APLS
+$15.4M
5
GSK icon
GSK
GSK
+$11.6M

Sector Composition

1 Healthcare 96.24%
2 Communication Services 1.96%
3 Financials 0%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$53.1M 8.76%
+954,738
2
$48.7M 8.05%
2,501,272
+40,135
3
$33.1M 5.47%
239,305
+64,102
4
$32.8M 5.41%
448,264
+341,879
5
$32.6M 5.38%
220,344
-55,150
6
$29.7M 4.91%
562,151
+209,600
7
$28.2M 4.65%
+232,676
8
$27.2M 4.49%
1,007,083
-1,006,384
9
$26.1M 4.31%
280,256
+259,485
10
$25M 4.13%
418,652
+4,571
11
$23.1M 3.82%
4,847,792
-2,694,580
12
$19.1M 3.15%
121,663
-142,240
13
$18.2M 3.01%
531,258
+225,773
14
$17.9M 2.96%
427,307
+70,279
15
$15.7M 2.59%
+760,551
16
$13.7M 2.27%
420,932
-478,542
17
$11.8M 1.96%
340,764
-33,520
18
$11.5M 1.9%
+71,731
19
$9.27M 1.53%
181,810
-226,647
20
$9.27M 1.53%
+712,698
21
$8.91M 1.47%
+548,325
22
$7.24M 1.2%
859,724
+615,087
23
$6.99M 1.15%
105,169
+28,710
24
$6.96M 1.15%
+132,655
25
$6.82M 1.13%
70,594
+42,842